Trials / Unknown
UnknownNCT05075915
Transfusion and COVID-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Alsace was particularly and early on affected by SARS-CoV-2 and quickly implemented a reduction in scheduled admissions and non-urgent surgical interventions, making it possible to reduce requests for labile blood products linked to non-urgent surgical procedures. as has been reported in the literature; the population containment measures also led to a major reduction in traffic - and consequently accidents on the public roads. At the same time, other demands for blood products related to activities such as onco-hematology were little affected. Finally, the blood banks have adapted their collection procedure. To answer these questions, we propose to conduct a retrospective study over two parallel periods of 2019 and 2020 of the consumption of blood products on the one hand and the availability of stocks on the other hand.
Conditions
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2021-10-13
- Last updated
- 2021-12-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05075915. Inclusion in this directory is not an endorsement.